We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Biogen Says Another Falls Ill After Taking MS Drug

Law360 (October 29, 2008, 12:00 AM EDT) -- For the third time since reintroducing the treatment to the market, Biogen Idec Inc. has said that a multiple sclerosis patient treated with its drug Tysabri has developed a rare but...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.